(Press-News.org)
Non-COVID-19-related deaths among people with diabetes increased during the pandemic, as did the diabetes complication of sight loss, according to a global study review led by a University of Massachusetts Amherst public health researcher that examined the impacts of pandemic-related disruptions on this vulnerable population.
The review, commissioned by the World Health Organization (WHO) and published Jan. 23 in The Lancet Diabetes and Endocrinology, looked at 138 studies comparing pre-pandemic to during pandemic periods in North America (39), Western Europe (39), Asia (17), Eastern Europe (14), South America (four), Egypt (one), Australia (one) and multiple regions (33).
“What we found overall was a fairly negative impact on diabetes outcomes,” says co-lead author Jamie Hartmann-Boyce, an assistant professor of health policy and promotion in the UMass Amherst School of Public Health and Health Sciences.
The review also found a startling increase in diabetes-related admissions to pediatric ICUs, as well as a rise in cases of diabetic ketoacidosis (DKA) among children and adolescents. Some of the cases were due to new-onset diabetes, meaning DKA – a serious, potentially life-threatening complication of diabetes – coincided with the diabetes diagnosis. There was no rise in the frequency or severity of DKA among adults.
In addition to an increase in deaths, “the data on pediatric ICU admissions and pediatric diabetes ketoacidosis is probably the most striking thing that comes out of this review,” Hartmann-Boyce says. “It was very consistent across countries, and a pediatric ICU admission is a major event for kids and their families.”
Hartmann-Boyce, who herself has lived with Type 1 diabetes since she was diagnosed at age 10, had initially conducted another WHO-commissioned study review on the direct impacts of the pandemic on people with diabetes. “We set out to answer the question, are you more at risk of dying from COVID and having serious disease if you have diabetes? And the data were clear – yes, you are,” she says.
After seeing clear evidence that diabetes was a risk factor for death from COVID-19, the United Kingdom-based team (Hartmann-Boyce joined UMass Amherst last year from her previous post at Oxford University in England) then became interested in looking at the pandemic’s indirect impacts on diabetes management.
“We know that not getting your eyes screened regularly if you have diabetes is a problem and leads to more sight loss,” Hartmann-Boyce says. “And we saw diabetes-related mortality and all-cause mortality increasing in England during the first wave that wasn’t attributed to COVID but was probably related to reduced access to health care and reduced health care utilization.”
The researchers note that there were more new cases of Type 1 diabetes than would have been expected, and children newly diagnosed with Type 1 diabetes were much sicker than during non-pandemic periods. Much less common than Type 2 diabetes, Type 1 diabetes is an autoimmune disease that is usually diagnosed in childhood but can occur at any age.
Often Type 1 diabetes is detected at routine primary care visits, as was the case for Hartmann-Boyce, whose diabetes was discovered from a urine test during her annual well child visit to the pediatrician. “If that had been me during the pandemic, I wouldn’t have had that visit, I wouldn’t have had that test and I would have had to get really sick before anyone knew there was something wrong,” she says.
Regardless of the type of diabetes a person has, the disease requires self-management with diet, physical activity and consistent routines. People with Type 1 diabetes also require insulin to manage their blood sugar.
“People had so much to say about the ways in which the pandemic had impacted their diabetes management,” says Hartmann-Boyce, whose team interviewed people with diabetes as part of their examination. “That really inspired us to do this research.”
She would like to update the review in the next decade or so, when more indirect pandemic impacts might become evident. “One of the interesting things about diabetes is, if you’re blood sugars run higher, there can be immediate impacts but also the impacts might not be seen for five or 10 years down the line,” Hartmann-Boyce says.
The negative impacts were most pronounced for females, younger people and racial and ethnic minority groups, according to the review, whose co-lead author is Patrick Highton, a research associate at the Diabetes Research Centre at the University of Leicester, U.K.
“One would hope that the people who do pandemic planning would take this information into account when thinking about the messaging and the care provided to people living with diabetes, should we have another pandemic,” Hartmann-Boyce says. “The review also points to the importance of ensuring all people with diabetes, but particularly those from less advantaged groups, have consistent access to diabetes medication and care.”
END
New database of 928 species of weeds from Universities of Sheffield and Oxford published to provide free, global resource for plant ecologists and archaeologists
The data changes our understanding of the history of agriculture as well as ability to understand the future of our farming practices in a time of climate change
The project, based on 30 years of research partnerships, is a testament to how academics of different disciplines can collaborate on globally significant research
A new database of weeds that can help scientists understand how ...
A ‘fitness check’ of regulations in five countries meant to protect animals during transportation, has deemed that they all fall short of fully protecting animals during transport. Findings from this interdisciplinary work involving animal welfare scientists and a law lecturer which compared animal transport rules designed to protect the billions of livestock that are transported on lengthy journeys in Australia, Canada, New Zealand, EU (including UK) and US, highlights serious failures.
The study, published in Royal Society Open Science today [Wednesday 24 January], and involving researchers from the Universities ...
Color mixing is the process of combining two or more colors: red and green make yellow, blue and red make purple, red and green and blue make white. This process of mixing colors is the basis for the future of solid-state lighting. While currently white light is achieved by phosphor down-conversion, LED color mixing actually has a higher theoretical maximum efficiency, which is needed in order to achieve the 2035 DOE energy efficiency goals. Despite the potential efficiency of color-mixed LED sources, there exists one significant challenge: green. ...
More than 2 billion people, approximately a quarter of the world’s population, lack access to clean drinking water. A new, portable and affordable water filtration solution created by researchers at The University of Texas at Austin aims to change that.
The new system collects dirty water with a syringe and injects it into a hydrogel filter that weeds out nearly all tiny particles. This device, the researchers say, offers significant advantages in cost, simplicity, effectiveness and sustainability compared existing commercial options, giving users the ability to easily decontaminate water from nearby streams and ...
The power of gravity is writ large across our visible universe. It can be seen in the lock step of moons as they circle planets; in wandering comets pulled off-course by massive stars; and in the swirl of gigantic galaxies. These awesome displays showcase gravity’s influence at the largest scales of matter. Now, nuclear physicists are discovering that gravity also has much to offer at matter’s smallest scales.
New research conducted by nuclear physicists at the U.S. Department of Energy’s Thomas Jefferson National Accelerator Facility is using a method that connects theories of gravitation to interactions among the smallest ...
Researchers from Cleveland Clinic and IBM have published a strategy for identifying new targets for immunotherapy through artificial intelligence (AI). This is the first peer-reviewed publication from the two organizations’ Discovery Accelerator partnership, designed to advance research in healthcare and life sciences.
The team worked together to develop supervised and unsupervised AI to reveal the molecular characteristics of peptide antigens, small pieces of protein molecules immune cells use to recognize threats. Project members ...
Everyone ruminates about the bad things that happen to them. Whether it’s a nasty breakup, an embarrassing failure or simply when someone is mean, it can be hard to stop thinking about what happened and why. For people who ruminate too much, this negative thought pattern can cause lasting problems with mental health.
A research team led from the University of California, Davis, Center for Mind and Brain found that adolescent girls who have a stronger tendency to ruminate show different patterns of brain activity when faced with social rejection. The study was ...
Neurons intricately communicate and respond to stimuli within a vast network, orchestrating essential functions from basic bodily processes to complex thoughts. Traditional neuroscience methods, relying on in vivo electrophysiology (within a living organism), often have difficulty addressing the complexity of the brain as a whole. An alternative approach involves extracting cells from the organism and conducting studies on a culture dish instead (in vitro), providing researchers with enhanced control and precision in measuring neural processes. In a new study featured in Advanced Science, researchers unveil a cost-effective, open-source in vitro system ...
While recent therapies have the potential to stall or delay the progression of multiple sclerosis, a new study shows that young Black and Hispanic women fare worse than young white women.
Minority women were more likely to have more advanced disease and faced greater challenges in pregnancy, the researchers reported in their study, publishing in the journal Neurology on Jan. 23, 2024.
Researchers tracked medical records at nine MS centers throughout the country for 294 women whose pregnancies resulted in live births. Approximately half of the patients ...
Combining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better than treatment with a single drug, a multi-institution, Phase 3 clinical trial led by UC San Francisco researchers has found.
The approach can extend the time between debilitating drug treatments without prolonging the time it takes to recover from each treatment.
Prostate cancer affects 1 in 8 men and causes 34,000 deaths each year in the United States. It is usually treated with one of several testosterone-lowering drugs for a set period of ...
